Munich - Delayed Quote EUR
Ardelyx Inc (41X.MU)
3.6740
-1.1230
(-23.41%)
At close: May 2 at 5:25:25 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
435,754
297,579
190,066
149,913
Total Liabilities Net Minority Interest
262,465
130,763
91,737
67,296
Total Equity Gross Minority Interest
173,289
166,816
98,329
82,617
Total Capitalization
324,142
216,638
98,329
82,617
Common Stock Equity
173,289
166,816
98,329
82,617
Capital Lease Obligations
2,585
6,160
9,749
13,240
Net Tangible Assets
173,289
166,816
98,329
82,617
Working Capital
278,622
195,718
88,000
80,828
Invested Capital
324,142
216,638
125,040
114,881
Tangible Book Value
173,289
166,816
98,329
82,617
Total Debt
153,438
55,982
36,460
45,504
Net Debt
85,921
28,352
--
--
Share Issued
238,015.8250
232,453.1900
198,575.0160
130,182.5350
Ordinary Shares Number
238,015.8250
232,453.1900
198,575.0160
130,182.5350
12/31/2021 - 11/18/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7SS.MU Brii Biosciences Ltd
0.2220
+2.78%
473A.SG Adaptimmune Therapeutics PLC
0.2440
+1.67%
IMR.F AC Immune SA
1.3940
-1.27%
MDG1.DE Medigene AG
0.1335
-27.64%
OCS Oculis Holding AG
18.87
+6.43%
ACET Adicet Bio, Inc.
0.6700
+6.60%
NKTX Nkarta, Inc.
2.0900
+1.95%
ADAP Adaptimmune Therapeutics plc
0.2859
+3.93%